Clinical Rheumatology

, 25:325 | Cite as

Incidence and clinical correlation of anticentromere antibody in Thai patients

  • Krisaree Pakunpanya
  • Oravan Verasertniyom
  • Monchand Vanichapuntu
  • Prapaporn Pisitkun
  • Kitti Totemchokchyakarn
  • Kanokrat Nantiruj
  • Suchela JanwityanujitEmail author
Original Article


Anticentromere antibodies (ACA) are useful in assessing and classifying patients with mild variant of systemic sclerosis called calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasias (CREST) syndrome. From their prognostic significance, we are interested in the prevalence and disease correlation in Thai patients. A total of 3,233 serum samples of patients with any musculoskeletal symptoms were sent for antinuclear antibody determination at Ramathibodi Immunology Laboratory Service between the years 1998 and 2001. Forty sera (1.23%) were ACA positive. These sera were from 27 patients with autoimmune diseases and 13 with nonautoimmune diseases. Among autoimmune group, scleroderma was the most common diagnosis (33.3%) with limited sclerosis being the most frequent variant. The percentages of autoimmune disease were almost the same among the low-titer (1:40) and the high-titer (1:640) groups. The study suggests that the prevalence of ACA in Thai patients is low. The presence of ACA detected in patients with vague musculoskeletal symptoms does not suggest a diagnosis of CREST syndrome. Even high-titer ACA can be found in nonautoimmune diseases.


Anticentromere antibodies Autoimmune diseases CREST syndrome Scleroderma Thai patients 


  1. 1.
    Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C (1980) Diversity of antinuclear antibodies in progressive systemic sclerosis: anticentromere antibody and its relationship to CREST syndrome. Arthritis Rheum 23:617–625PubMedCrossRefGoogle Scholar
  2. 2.
    Fritzler MJ, Kinsella TD (1980) The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 69:520–526CrossRefPubMedGoogle Scholar
  3. 3.
    Tuffanelli DL, McKeon F, Kleinsmith DM, Burnham TK, Kirschner M (1983) Anticentromere and anticentriole antibodies in the scleroderma spectrum. Arch Dermatol 119:560–566CrossRefPubMedGoogle Scholar
  4. 4.
    Vazquez-Abad D, Grodzicky T, Senecal JL (1999) Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis. Clin Immunol 90:182–189CrossRefPubMedGoogle Scholar
  5. 5.
    Chan HL, Lee YS, Hong HS, Kuo TT (1994) Anticentromere antibodies (ACA): clinical distribution and disease specificity. Clin Exp Dermatol 19:298–302PubMedCrossRefGoogle Scholar
  6. 6.
    Sato S, Fujimoto M, Ihn H, Takehara K (1994) Antibodies to centromere and centriole in scleroderma spectrum disorders. Dermatology 189:23–26PubMedCrossRefGoogle Scholar
  7. 7.
    Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI et al (1989) Prevalence of scleroderma spectrum disorders in the general populations of South Carolina. Arthritis Rheum 32:998–1002PubMedCrossRefGoogle Scholar
  8. 8.
    Medsger TA (1994) Systemic sclerosis (scleroderma). In: Stein JH, Hutton JJ. Kohler Po et al (eds). Internal medicine, 4th edn. Mosby Year Book, St. Louise, MO, pp 2443–2449Google Scholar
  9. 9.
    Kallenberg CGM, Pastoor GW, Wouda AA et al (1982) Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis 41:382–387PubMedCrossRefGoogle Scholar
  10. 10.
    Chorzelski TP, Jablonska S, Beutner EH, Blaszczyk M, Jarzabek-Chorzelska M, Kencha D et al (1985) Anticentromere antibody: an immunological marker of a subset of systemic sclerosis. Br J Dermatol 113:381–9PubMedCrossRefGoogle Scholar
  11. 11.
    Powell FC, Winkelmann RK, Venencie-Lemarchand F, Spurbeck JL, Schroeter AL (1984) The anticentromere antibody: disease specificity and clinical significance. Mayo Clin Proc 59:700–706Google Scholar
  12. 12.
    Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderrma). Arthritis Rheum 23:581–590CrossRefGoogle Scholar
  13. 13.
    Arnett FC, Edworthy SM, Block DA, Mcshane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  14. 14.
    Vlachoyiannopauplos PG, Drosos AA, Wiik A, Moutsopoulos HM (1993) Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 32:297–301PubMedCrossRefGoogle Scholar
  15. 15.
    Caramaschi P, Biasi D, Manzo T, Carletto A, Poli F, Bambara LM (1995) Anticentromere antibody-clinical associations: a study of 44 patients. Rheumatol Int 14:253–255PubMedCrossRefGoogle Scholar
  16. 16.
    McCarty GA, Rice JR, Bembe ML, Barada FA Jr (1983) Anticentromere antibody. Clinical correlations and association with favorable prognosis in patients with scleroderma variants. Arthritis Rheum 26:1–7PubMedCrossRefGoogle Scholar
  17. 17.
    Miller HM, Littlejohn GO, Davidson A, Jones B, Topliss DJ (1987) The clinical significance of the anticentromere antibody. Br J Rheumatol 26:17–21PubMedCrossRefGoogle Scholar
  18. 18.
    Sun D, Martinez A, Sullivan KF, Sharp GC, Hoch SO (1996) Detection of anticentromere antibodies using recombinant human CENP-A protein. Arthritis Rheum 39:863–867PubMedCrossRefGoogle Scholar
  19. 19.
    Martinez A, Sun D, Billings PB, Swiderek KM, Sullivan KF, Hoch SO (1998) Isolation and comparison of natural and recombinant human CENP-A autoantigen. J Autoimmun 11:611–619PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2005

Authors and Affiliations

  • Krisaree Pakunpanya
    • 1
  • Oravan Verasertniyom
    • 2
  • Monchand Vanichapuntu
    • 2
  • Prapaporn Pisitkun
    • 1
  • Kitti Totemchokchyakarn
    • 1
  • Kanokrat Nantiruj
    • 1
  • Suchela Janwityanujit
    • 1
    Email author
  1. 1.Division of Allergy, Immunology and Rheumatology, Faculty of MedicineRamathibodi HospitalBangkokThailand
  2. 2.Research Center, Faculty of Medicine, Ramathibodi HospitalMahidol UniversityBangkokThailand

Personalised recommendations